Arthur Nádas

5.2k total citations
113 papers, 3.4k citations indexed

About

Arthur Nádas is a scholar working on Virology, Artificial Intelligence and Molecular Biology. According to data from OpenAlex, Arthur Nádas has authored 113 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Virology, 22 papers in Artificial Intelligence and 19 papers in Molecular Biology. Recurrent topics in Arthur Nádas's work include HIV Research and Treatment (33 papers), Immune Cell Function and Interaction (17 papers) and Speech Recognition and Synthesis (15 papers). Arthur Nádas is often cited by papers focused on HIV Research and Treatment (33 papers), Immune Cell Function and Interaction (17 papers) and Speech Recognition and Synthesis (15 papers). Arthur Nádas collaborates with scholars based in United States, Cameroon and India. Arthur Nádas's co-authors include D. Nahamoo, Kazuhiko Ito, Susan Zolla‐Pazner, Isaac Meilijson, Michael Picheny, Miroslaw K. Górny, Phillipe N. Nyambi, Morton Lippmann, Dimitri Kanevsky and George D. Thurston and has published in prestigious journals such as PLoS ONE, Technometrics and Journal of Virology.

In The Last Decade

Arthur Nádas

107 papers receiving 3.2k citations

Peers

Countries citing papers authored by Arthur Nádas

Since Specialization

Citations

This map shows the geographic impact of Arthur Nádas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Nádas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Nádas more than expected).

Fields of papers citing papers by Arthur Nádas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur Nádas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Nádas. The network helps show where Arthur Nádas may publish in the future.

Co-authorship network of co-authors of Arthur Nádas

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur Nádas. A scholar is included among the top collaborators of Arthur Nádas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur Nádas. Arthur Nádas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity 2024 ·Frontiers in Immunology ·Chitra Upadhyay, P. S. Rao, Mohammad Amin Behzadi, (unknown), (unknown), (unknown), (unknown), Weiming Yang, Xunqing Jiang, Christina C. Luo, Arthur Nádas, James Arthos, Xiang‐Peng Kong, Hui Zhang, Catarina E. Hioe, J. Andrew Duty	2
2	Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1 2023 ·Frontiers in Immunology ·Catarina E. Hioe, (unknown), (unknown), Daniel W. Heindel, Jéromine Klingler, (unknown), Christina C. Luo, Xunqing Jiang, Shilpi Pandey, (unknown), Philip Barnette, Maxim Totrov, Jiang Zhu, Arthur Nádas, Susan Zolla‐Pazner, Chitra Upadhyay, Xiaoying Shen, Xiang‐Peng Kong, Ann J. Hessell	1
3	Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials 2018 ·Scientific Reports ·Preetha Balasubramanian, Constance Williams, (unknown), Faruk Sinangil, Keith Higgins, Arthur Nádas, Maxim Totrov, Xiang‐Peng Kong, Andrew Fioré-Gartland, Nancy L. Haigwood, Susan Zolla‐Pazner, Catarina E. Hioe	19
4	Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals 2013 ·Virology ·Raiees Andrabi, Constance Williams, Xiaohong Wang, Liuzhe Li, Alok Choudhary, Naveet Wig, Ashutosh Biswas, Kalpana Luthra, Arthur Nádas, Michael S. Seaman, Phillipe N. Nyambi, Susan Zolla‐Pazner, Miroslaw K. Górny	15
5	Different Pattern of Immunoglobulin Gene Usage by HIV-1 Compared to Non-HIV-1 Antibodies Derived from the Same Infected Subject 2012 ·PLoS ONE ·Liuzhe Li, Xiaohong Wang, Sagarika Banerjee, Barbara Volsky, Constance Williams, (unknown), Arthur Nádas, Michael S. Seaman, Xuemin Chen, Paul Spearman, Susan Zolla‐Pazner, Miroslaw K. Górny	21
6	Superinfection by Discordant Subtypes of HIV-1 Does Not Enhance the Neutralizing Antibody Response against Autologous Virus 2012 ·PLoS ONE ·Luzia Mayr, Rebecca Powell, (unknown), (unknown), Arthur Nádas, Phillipe N. Nyambi	6
7	Cross-Clade HIV-1 Neutralizing Antibodies Induced with V3-Scaffold Protein Immunogens following Priming with gp120 DNA 2011 ·Journal of Virology ·Susan Zolla‐Pazner, Xiang‐Peng Kong, Xunqing Jiang, Timothy Cardozo, Arthur Nádas, Sandra Cohen, Maxim Totrov, Michael S. Seaman, Shixia Wang, Shan Lu	50
8	In Vitro Restoration of Th17 Response During HIV Infection with an Antiretroviral Drug and Th17 Differentiation Cytokines 2011 ·AIDS Research and Human Retroviruses ·Yelina Alvarez, Michael Tuen, Arthur Nádas, Catarina E. Hioe	13
9	Global Levels of Histone Modifications in Peripheral Blood Mononuclear Cells of Subjects with Exposure to Nickel 2011 ·Environmental Health Perspectives ·Adriana Arita, Jingping Niu, Qingshan Qu, (unknown), Ye Ruan, Arthur Nádas, Yana Chervona, Fen Wu, Hong Sun, Richard B. Hayes, Max Costa	74
10	HIV Envelope gp120 Activates LFA-1 on CD4 T-Lymphocytes and Increases Cell Susceptibility to LFA-1-Targeting Leukotoxin (LtxA) 2011 ·PLoS ONE ·Catarina E. Hioe, Michael Tuen, Gaia Vasiliver-Shamis, Yelina Alvarez, Kathleen C. Prins, Sagarika Banerjee, Arthur Nádas, Michael W. Cho, Michael L. Dustin, Scott C. Kachlany	32
11	Worldwide Distribution of HIV Type 1 Epitopes Recognized by Human Anti-V3 Monoclonal Antibodies 2009 ·AIDS Research and Human Retroviruses ·Timothy Cardozo, (unknown), Abraham Pinter, Chavdar Krachmarov, Arthur Nádas, (unknown), Susan Zolla‐Pazner	23
12	Analyzing the Cost of a Cache Miss Using Pipeline Spectroscopy 2008 ·Thomas R. Puzak, A. Hartstein, Philip Emma, Vijayalakshmi Srinivasan, Arthur Nádas	2
13	Neutralization Patterns and Evolution of Sequential HIV Type 1 Envelope Sequences in HIV Type 1 Subtype B-Infected Drug-Naive Individuals 2008 ·AIDS Research and Human Retroviruses ·Phillipe N. Nyambi, Sherri Burda, Mateusz M. Urbanski, Leo Heyndríckx, Wouter Janssens, Guido Vanham, Arthur Nádas	5
14	Gene expression levels in normal human lymphoblasts with variable sensitivities to arsenite: Identification of GGT1 and NFKBIE expression levels as possible biomarkers of susceptibility 2007 ·Toxicology and Applied Pharmacology ·Elena V. Komissarova, Ping Li, Ahmed Uddin, (unknown), Arthur Nádas, Toby G. Rossman	7
15	Airport-Related Air Pollution and Noise 2007 ·Journal of Occupational and Environmental Hygiene ·Beverly S. Cohen, Arline L. Bronzaft, (unknown), (unknown), Arthur Nádas	19
16	Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G 2006 ·Journal of Medical Virology ·Frank Konings, Sherri Burda, Mateusz M. Urbanski, Ping Zhong, Arthur Nádas, Phillipe N. Nyambi	47
17	The ‘Fishing License’ method for analysing the time course of effects in repeated measurements 2004 ·Statistics in Medicine ·Christine Nadziejko, Lung‐Chi Chen, Arthur Nádas, Jing‐Shiang Hwang	10
18	HIV Infection in Rural Villages of Cameroon 2002 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Phillipe N. Nyambi, Léopold Zekeng, (unknown), Marcel Tongo, Aubin Nanfack, (unknown), (unknown), (unknown), Sherri Burda, Henry A. Mbah, Lucy Agyingi, Ping Zhong, Arthur Nádas, Susan Zolla‐Pazner, Michael Marmor	43
19	The tar fraction of cigarette smoke does not promote arteriosclerotic plaque development. 1996 ·Environmental Health Perspectives ·Arthur Penn, Kathleen Keller, Conway W. Snyder, Arthur Nádas, Lung‐Chi Chen	17
20	A Confidence Region for the Log-Normal Hazard Function 1969 ·Technometrics ·Arthur Nádas	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact